James Dodge is the Head of Neuroimmunometabolic Research Cluster at Sanofi, where they currently lead projects focused on developing therapies for rare neurometabolic, neuromuscular, and neurodegenerative diseases. They hold a Ph.D. in Behavioral Neuroscience from the State University of New York at Buffalo and have over 22 years of industry experience. Previously, James worked at Genzyme in various scientific roles, including Principal Scientist, and has contributed significantly to the field with 41 publications in top-tier journals and multiple patents. James is recognized for their expertise in lipidomic and global metabolic pathway analysis and excels in management, leadership, and communication within collaborative environments.
This person is not in the org chart
This person is not in any teams
This person is not in any offices